The renal denervation market size was valued at $156,327.4 thousand in 2020, and is estimated to reach $4,555,983.0 thousand by 2030, growing at a CAGR of 40.7% from 2021 to 2030. Renal denervation is a type of irregular heartbeat characterized by rapid and irregular beating. Owing to the disorder, ventricles receive insufficient blood. Blood may clot and congest in the atria at the same time.These clots can enter the circulation and reach the brain causing stroke. The transmission of electrical impulses to the lower heart chambers is disrupted in renal denervation, which is expected to cause a rapid, slow, or irregular heartbeat. During renal denervation, upper chamber and lower chamber of the heart beat irregularly, chaotically, and out of sync, which can cause shortness of breath, chest pain, weakness, lightheadedness, or fainting.
Get Free Sample PDF of Renal Denervation Market:
https://www.alliedmarketresearch.com/request-sample/522
The market is expected to expand as the rise in prevalence and incidence of hypertension &blood pressure. Moreover, changing lifestyles and improvement in healthcare infrastructure in developing nations have fueled the renal denervation market growth. In addition, the renal denervation process is more cost efficient than other multi-drug therapy treatments.However, the market’s growth is hampered by the extensive approval process for renal denervation devices, as well as patient discomfort and anxiety during the treatment.
The renal denervation market is expected to witness a significant growth in the coming future. The renal denervation market has gained interest of the healthcare and medical sectors owing to increased prevalence of hypertension throughout the globe. Furthermore, availability of alternative and better technologies for renal denervation systems, such as micro-infusion, as well as expanding healthcare infrastructure in emerging nations are expected to promote market growth. For example, Mercator MedSystem’s renal denervation technology is based on micro-infusion. It distributes chemicals to a precise location to denervate the renal artery, which helps in lowering patient blood pressure.
Various market players have adopted strategies to expand its business and strengthen its market position. For instance, in 2019, Abbott Laboratories, manufacturer of medical devices and technologies has acquired St. Jude Medical to offer renal denervation systems for treatment of hypertension. It offers EnligHTN Renal Denervation, which enables latest efficiencies in treating hypertension. It also reduces systolic blood pressure in patient. As a result, key players have acquired other companies to offer renal denervation systems that fuel the market growth.
Ask more about Renal Denervation Market:
https://www.alliedmarketresearch.com/purchase-enquiry/522
Key Findings Of The Study
- The report provides an extensive analysis of the current and emerging renal denervation market trends and dynamics.
- Depending on product, the Enlightn segment dominated the renal denervation market, in terms of revenue in 2020 and the Vessix segment is projected to grow at a significant CAGR during the forecast period.
- By technology, the radio frequency segment has registered highest renal denervation market share in 2020.
- By end user, the hospitals segment has registered highest revenue in 2020.
- Europe is projected to register highest growth rate in the coming years.
- The key players within the renal denervation market are profiled in this report, and their strategies are analyzed thoroughly, which help understand competitive outlook of the renal denervation industry.
- The report provides an extensive analysis of the current trends and emerging opportunities of the market.
- In-depth renal denervation market analysis is conducted by estimations for the key segments between 2021 and 2030.
Table of Content:
- CHAPTER 1: INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
However, during the pandemic, various manufacturers in the renal denervation market had to stop their business in countries such as China, the U.S., and India. Thisbreak directly impacted sales of renal denervation companies. In addition, lack of manpower and raw materials also constricted supply of equipment of renal denervation that has negatively influenced the growth of the market. However, reopening of production facilities and introduction of vaccines for coronavirus disease are anticipated to lead to re-opening of renal denervation companies.
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Contact Us:
David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975